Screener
Madrigal Pharmaceuticals, Inc. MDGL Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Loss from operations | (56,308) | (47,202) | (149,031) | (126,513) |
| Interest income | 7,104 | 8,227 | 15,347 | 17,597 |
| Interest expense | (7,940) | (3,264) | (15,759) | (6,561) |
| Other expense, net | (795) | (42) | (2,887) | (42) |
| Net loss | $(57,939) | $(42,281) | $(152,330) | $(115,519) |
| Net loss per common, Series A preferred and Series B preferred share: | ||||
| Basic and diluted net loss per common, Series A preferred, and Series B preferred share | $(1.99) | $(1.50) | $(5.24) | $(4.10) |
| Basic and diluted weighted average number of shares outstanding (Note 13) | 29,145,271 | 28,232,604 | 29,089,148 | 28,159,333 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s net income?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported net income of -$57.94M in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s net income changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s net income decreased by 37.0% year-over-year, from -$42.28M to -$57.94M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s net income?
- Over 4 years (2021 to 2025), Madrigal Pharmaceuticals, Inc.'s net income has grown at a 4.5% compound annual growth rate (CAGR), from -$241.85M to -$288.28M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude